General Info
Leaps by Bayer invests in life sciences and specializes in the fields of biotechnology, agriculture, and scientific breakthrough.
Location: Leverkusen
Country:
Industries:
Investment Regions: EU
Investment Stages: seed, series-a
Website: https://leaps.bayer.com/
corporate-vc
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: Leaps by Bayer’s website press releases show investments in 2025, including a press release on 06-30-2025 (AbbVie to Acquire Capstan Therapeutics) and other activity in 2025 (e.g., Jan 20, 2025). The most recent clear investment-related press release on the Leaps site is 06-30-2025; that date is between 6 and 3 months before the reference date, indicating the ‘active’ classification. One of the startups mentioned in the 2025 press releases is Capstan Therapeutics.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Leaps by Bayer
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI